Abstract:Background: There is evidence that vitamin B12 and associated metabolite levels are changed in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH); however, their association has been in dispute. Methods: We included 8397 individuals without previous liver condition or excess alcohol intake from the National Health and Nutrition Examination Survey (NHANES) 1999–2004. NAFLD was diagnosed with Fatty Liver Index (FLI) ≥ 60 or USFLI ≥ 30, and participants with advanced fibrosis risks were identified with elevated non-alcoholic fatty liver disease fibrosis score (NFS), fibrosis 4 index (FIB-4), or aspartate aminotransferase (AST)/platelet ratio index (APRI). Step-wide logistic regression adjusting for confounders was used to detect the association between NAFLD or advanced fibrosis with serum vitamin B12, folate, red blood cell folate (RBC folate), homocysteine (HCY), and methylmalonic acid (MMA). Results: The weighted prevalence of NAFLD was 44.2%. Compared with non-NAFLD participants, patients with NAFLD showed significantly increased RBC folate level and RBC counts, decreased serum vitamin B12 and folate, and similar HCY and MMA levels. NAFLD with advanced fibrosis risk had higher MMA and HCY, reduced serum vitamin B12, and similar serum folate and RBC folate levels than NAFLD with low fibrosis risk. Only RBC folate was independently associated with an increased risk of NAFLD (OR (95% CI): 2.24 (1.58, 3.18)). In all participants, MMA (OR: 1.41 (1.10, 1.80)) and HCY (OR: 2.76 (1.49, 5.11)) were independently associated with increased risk for advanced fibrosis. In participants with NAFLD, this independent association still existed (OR: 1.39 (1.04, 1.85) for MMA and 1.95 (1.09, 3.46) for HCY). In all participants, the area under the receiver operating characteristic curve (ROC AUC) on fibrosis was 0.6829 (0.6828, 0.6831) for MMA and 0.7319 (0.7318, 0.7320) for HCY; in participants with NAFLD, the corresponding ROC AUC was 0.6819 (0.6817, 0.6821) for MMA and 0.6926 (0.6925, 0.6928) for HCY. Conclusion: Among vitamin B12-associated biomarkers, RBC folate was independently associated with elevated NAFLD risk, whereas MMA and HCY were associated with increased risk for advanced fibrosis in the total population and NAFLD participants. Our study highlighted the clinical diagnostic value of vitamin B12 metabolites and the possibility that vitamin B12 metabolism could be a therapeutic target for NASH. Further studies using recent perspective data with biopsy proven NASH could be conducted to validate our results.

Association of Serum Methionine Metabolites with Non-Alcoholic Fatty Liver Disease: a Cross-Sectional Study

Association Between Serum Free Fatty Acid Levels and Nonalcoholic Fatty Liver Disease: a Cross-Sectional Study

Serum Sialic Acid Level Is Significantly Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: A Cross-Sectional Study

Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease

Relationship Between Alanine Aminotransferase Levels and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease

ASSA13-10-11 Nonalcoholic Fatty Liver Disease is Associated with Subclinical Atherosclerosis

Relationship of Serum Uric Acid Level with Non-Alcoholic Fatty Liver Disease and Its Inflammation Progression in Non-Obese Adults.

Serum Complement C3 Levels Are Associated with Nonalcoholic Fatty Liver Disease Independently of Metabolic Features in Chinese Population

Relationship Between Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.

Associations of Gut-Flora-dependent Metabolite Trimethylamine-N-oxide, Betaine and Choline with Non-Alcoholic Fatty Liver Disease in Adults

Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

Serum Creatinine Levels and Risk of Nonalcohol Fatty Liver Disease in a Middle-Aged and Older Chinese Population: A Cross-Sectional Analysis.

Adiposity, Metabolomic Biomarkers, and Risk of Nonalcoholic Fatty Liver Disease: a Case-Cohort Study

Serum Uric Acid and Non-Alcoholic Fatty Liver Disease in Non-Diabetic Chinese Men

Higher S-adenosylhomocysteine and Lower Ratio of S-adenosylmethionine to S-adenosylhomocysteine Were More Closely Associated with Increased Risk of Subclinical Atherosclerosis Than Homocysteine

Serum Folic Acid Levels Are Associated with the Presence and Severity of Liver Steatosis in Chinese Adults.

Associations of Arsenic Exposure and Arsenic Metabolism with the Risk of Non-Alcoholic Fatty Liver Disease.

The Association Between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999–2004

METABOLIC ABNORMALITIES, LIVER AND BODY FAT IN AMERICAN VERSUS CHINESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE

Non‐alcoholic Fatty Liver Disease's Prevalence and Impact on Alanine Aminotransferase Associated with Metabolic Syndrome in the Chinese

The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China